191 related articles for article (PubMed ID: 35348737)
1. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer.
Wang W; McMillan MT; Zhao X; Wang Z; Jiang L; Karnak D; Lima F; Parsels JD; Parsels LA; Lawrence TS; Frankel TL; Morgan MA; Green MD; Zhang Q
Mol Cancer Res; 2022 Jul; 20(7):1137-1150. PubMed ID: 35348737
[TBL] [Abstract][Full Text] [Related]
2. DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy.
Carr MI; Chiu LY; Guo Y; Xu C; Lazorchak AS; Yu H; Qin G; Qi J; Marelli B; Lan Y; Sun Q; Czauderna F; Zenke FT; Blaukat A; Vassilev LT
Mol Cancer Res; 2022 Apr; 20(4):568-582. PubMed ID: 34980594
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models.
Zenke FT; Zimmermann A; Sirrenberg C; Dahmen H; Kirkin V; Pehl U; Grombacher T; Wilm C; Fuchss T; Amendt C; Vassilev LT; Blaukat A
Mol Cancer Ther; 2020 May; 19(5):1091-1101. PubMed ID: 32220971
[TBL] [Abstract][Full Text] [Related]
4. DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia.
Haines E; Nishida Y; Carr MI; Montoya RH; Ostermann LB; Zhang W; Zenke FT; Blaukat A; Andreeff M; Vassilev LT
Sci Rep; 2021 Jun; 11(1):12148. PubMed ID: 34108527
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.
Zhang Q; Green MD; Lang X; Lazarus J; Parsels JD; Wei S; Parsels LA; Shi J; Ramnath N; Wahl DR; Pasca di Magliano M; Frankel TL; Kryczek I; Lei YL; Lawrence TS; Zou W; Morgan MA
Cancer Res; 2019 Aug; 79(15):3940-3951. PubMed ID: 31101760
[TBL] [Abstract][Full Text] [Related]
6. Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer.
Zhang Q; Jiang L; Wang W; Huber AK; Valvo VM; Jungles KM; Holcomb EA; Pearson AN; The S; Wang Z; Parsels LA; Parsels JD; Wahl DR; Rao A; Sahai V; Lawrence TS; Green MD; Morgan MA
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38376927
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
Sun Q; Guo Y; Liu X; Czauderna F; Carr MI; Zenke FT; Blaukat A; Vassilev LT
Mol Cancer Res; 2019 Dec; 17(12):2457-2468. PubMed ID: 31551253
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer.
Gordhandas SB; Manning-Geist B; Henson C; Iyer G; Gardner GJ; Sonoda Y; Moore KN; Aghajanian C; Chui MH; Grisham RN
Sci Rep; 2022 Jan; 12(1):974. PubMed ID: 35046420
[TBL] [Abstract][Full Text] [Related]
10. Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.
Liu C; Wang X; Qin W; Tu J; Li C; Zhao W; Ma L; Liu B; Qiu H; Yuan X
Cancer Commun (Lond); 2023 Apr; 43(4):435-454. PubMed ID: 36855844
[TBL] [Abstract][Full Text] [Related]
11. Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.
Matsumoto Y
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457081
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells.
Azad A; Jackson S; Cullinane C; Natoli A; Neilsen PM; Callen DF; Maira SM; Hackl W; McArthur GA; Solomon B
Mol Cancer Res; 2011 Dec; 9(12):1696-707. PubMed ID: 22009179
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer.
Smithson M; Irwin RK; Williams G; McLeod MC; Choi EK; Ganguly A; Pepple A; Cho CS; Willey CD; Leopold J; Hardiman KM
Neoplasia; 2022 Mar; 25():53-61. PubMed ID: 35168148
[TBL] [Abstract][Full Text] [Related]
14. Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models.
Wise HC; Iyer GV; Moore K; Temkin SM; Gordon S; Aghajanian C; Grisham RN
Sci Rep; 2019 Dec; 9(1):18882. PubMed ID: 31827119
[TBL] [Abstract][Full Text] [Related]
15. Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression.
Wang X; Huang J; Liu F; Yu Q; Wang R; Wang J; Zhu Z; Yu J; Hou J; Shim JS; Jiang W; Li Z; Zhang Y; Dang Y
J Clin Invest; 2023 May; 133(9):. PubMed ID: 36928177
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment.
Friedmann BJ; Caplin M; Savic B; Shah T; Lord CJ; Ashworth A; Hartley JA; Hochhauser D
Mol Cancer Ther; 2006 Feb; 5(2):209-18. PubMed ID: 16505093
[TBL] [Abstract][Full Text] [Related]
17. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition.
Ćmielová J; Havelek R; Vávrová J; Řezáčová M
Med Oncol; 2015 May; 32(5):138. PubMed ID: 25801233
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus Transduction in Mammalian Cells Is Affected by the Production of Type I and III Interferons, Which Is Mediated Mainly by the cGAS-STING Pathway.
Amalfi S; Molina GN; Bevacqua RJ; López MG; Taboga O; Alfonso V
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796076
[TBL] [Abstract][Full Text] [Related]
19. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway.
Ding C; Song Z; Shen A; Chen T; Zhang A
Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501
[TBL] [Abstract][Full Text] [Related]
20. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.
Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ
Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
